An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
The Froedtert & MCW health network has been using the Xealth digital health platform, which is integrated into its EHR system ...
Novartis has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by ...
Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...
The Committee for Medicinal Products for Human Use adopted a positive opinion for NVS' Kisqali to help reduce the risk of recurrence in people with HR+/HER2- early breast cancer.
As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...
European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...
Terns Pharmaceuticals' (TERN) stock has risen somewhat due to some optimism around its early-stage clinical programs ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback